Optifarm
ActiveSummary
Optifarm has been active since 1970 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €412,960 and a net result of €71,877. Equity is growing by about 7% per year across the filed financial years. Its solvency ranks better than 27% of 12,724 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 1.0% (low).
Directors
Not every act has been read: a resignation may still be missing
Mandate history
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| MELIDA BVfrom an act |
|
| GROEP MELIDA BV |
|
Owners and capital
Owners
1 ownerChain of control
- GROEP MELIDA
- Optifarm
Highest known parent: GROEP MELIDA. The sources do not say who stands above it.
Owners 1
- GROEP MELIDAparent100%
Sources: the companies' annual accounts, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Capital and shareholders
- CLAEYS - DECRAENE (BE 0455.740.642) 198 shares · 99%
- GROEP MELIDA BV 2 shares
The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.
- 07-12-2022 Capital increase of €20,625 · 750 new shares
- 07-12-2022 Capital increase of €20,625 · 750 new shares
- 07-12-2022 Converted to unavailable equity
- 19-09-2022 Capital stated in the deed · €20,000 · 200 shares